Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Genelux Corp (GNLX)

Genelux Corp (GNLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 58,742
  • Shares Outstanding, K 34,352
  • Annual Sales, $ 170 K
  • Annual Income, $ -28,300 K
  • 60-Month Beta -1.57
  • Price/Sales 394.04
  • Price/Cash Flow N/A
  • Price/Book 3.47
Trade GNLX with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.19
  • Number of Estimates 2
  • High Estimate -0.12
  • Low Estimate -0.26
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +9.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.7100 unch
on 07/02/24
2.8300 -39.58%
on 06/03/24
-1.0000 (-36.90%)
since 05/31/24
3-Month
1.7100 unch
on 07/02/24
5.7500 -70.26%
on 05/22/24
-3.5400 (-67.43%)
since 04/02/24
52-Week
1.7100 unch
on 07/02/24
35.1500 -95.14%
on 07/13/23
-31.0100 (-94.77%)
since 06/30/23

Most Recent Stories

More News
Young Adults and Pancreatic Cancer: What the 80% Rise in Diagnoses Means for Future Treatment

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GNLX),(NASDAQ:CRNX),(NYSE:PFE),(NASDAQ:SGEN) EQNX::TICKER_END

ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
GNLX : 1.7100 (-7.07%)
CRNX : 45.54 (-1.15%)
PFE : 27.83 (-1.38%)
SGEN : 228.74 (-0.07%)
Navigating the Surge in Pancreatic Cancer: The Innovative Strategies Offering New Hope

USA News Group – Researchers are becoming increasingly concerned with the rates of cancer on the rise among people under 50. A recent study found a nearly 80% global increase in the number of under-50s...

ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
GNLX : 1.7100 (-7.07%)
CRNX : 45.54 (-1.15%)
PFE : 27.83 (-1.38%)
SGEN : 228.74 (-0.07%)
Why Shares of Genelux Climbed This Week

The company's shares rose on signs it might be getting closer to its first biologics license application.

GNLX : 1.7100 (-7.07%)
Why Shares of Genelux Corporation Jumped This Week

The company reported positive phase 2 trial news regarding its lead therapy.

GNLX : 1.7100 (-7.07%)

Business Summary

Genelux Corporation is a clinical-stage biopharmaceutical company. It focused on developing a pipeline of next-generation oncolytic immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. The Company's most advanced product candidate, Olvi-Vec, is a proprietary,...

See More

Key Turning Points

3rd Resistance Point 1.9750
2nd Resistance Point 1.9220
1st Resistance Point 1.8160
Last Price 1.7100
1st Support Level 1.6570
2nd Support Level 1.6040
3rd Support Level 1.4980

See More

52-Week High 35.1500
Fibonacci 61.8% 22.3759
Fibonacci 50% 18.4300
Fibonacci 38.2% 14.4841
Last Price 1.7100
52-Week Low 1.7100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar